Prominence of the dopamine D2 short isoform in dopaminergic pathways.

As a result of alternative splicing, the D2 gene of the dopamine receptor family exists in two isoforms. The D2 long is characterized by the insertion of 29 amino acids in the third cytoplasmic loop, which is absent in the short isoform. We have produced subtype-specific antibodies against both the D2 short and D2 long isoforms and found a unique compartmentalization between these two isoforms in the primate brain. The D2 short predominates in the cell bodies and projection axons of the dopaminergic cell groups of the mesencephalon and hypothalamus, whereas the D2 long is more strongly expressed by neurons in the striatum and nucleus accumbens, structures targeted by dopaminergic fibers. These results show that the splice variants of the dopamine D2 receptor are differentially distributed and possess distinct functions. The strategic localization of the D2 short isoform in dopaminergic cell bodies and axons strongly suggests that this isoform is the likely dopamine autoreceptor, whereas the D2 long isoform is primarily a postsynaptic receptor.

[1]  R. G. Allen,et al.  Pituitary Lactotroph Hyperplasia and Chronic Hyperprolactinemia in Dopamine D2 Receptor-Deficient Mice , 1997, Neuron.

[2]  Christer Halldin,et al.  Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients , 1993, Biological Psychiatry.

[3]  A. Takahashi,et al.  Regulation of Dopamine D1 and D2 Receptors on Striatal Acetylcholine Release in Rats , 1997, Brain Research Bulletin.

[4]  M. Martres,et al.  Alternative splicing directs the expression of two D2 dopamine receptor isoforms , 1989, Nature.

[5]  C. Gerfen,et al.  D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. , 1990, Science.

[6]  S. Cragg,et al.  Differential Autoreceptor Control of Somatodendritic and Axon Terminal Dopamine Release in Substantia Nigra, Ventral Tegmental Area, and Striatum , 1997, The Journal of Neuroscience.

[7]  P. Goldman-Rakic,et al.  A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[8]  F. J. White,et al.  Alterations in Dopamine Release But Not Dopamine Autoreceptor Function in Dopamine D3 Receptor Mutant Mice , 1998, The Journal of Neuroscience.

[9]  A. Parent,et al.  Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidium in basal ganglia circuitry , 1995, Brain Research Reviews.

[10]  G. Aston-Jones,et al.  Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome , 1994, Nature.

[11]  T. Pugsley,et al.  A rapid filtration assay for soluble receptors using polyethylenimine-treated filters. , 1983, Analytical biochemistry.

[12]  A. Gutiérrez,et al.  Short and Long Form γ2 Subunits of the GABAA/Benzodiazepine Receptors , 1994 .

[13]  L. Snyder,et al.  Distribution of dopamine D2 receptor mRNA splice variants in the rat by solution mhybridization/protection assay , 1991, Neuroscience Letters.

[14]  P. Calabresi,et al.  Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice. , 1997, Neuroscience.

[15]  S. Sesack,et al.  Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[16]  K. Neve,et al.  Dopamine Receptors , 2008 .

[17]  G. Reynolds.  Dopamine receptors and schizophrenia. , 1996, Biochemical Society transactions.

[18]  P. Laduron,et al.  Solubilisation of high-affinity dopamine receptors , 1979, Nature.

[19]  C. Gerfen,et al.  Multiple D2 dopamine receptors produced by alternative RNA splicing , 1989, Nature.

[20]  J. Mallet,et al.  Antibodies to the Human γ2 Subunit of the γ‐Aminobutyric AcidA/Benzodiazepine Receptor , 1993 .

[21]  P. Goldman-Rakic,et al.  Localization of dopamine D4 receptors in GABAergic neurons of the primate brain , 1996, Nature.

[22]  P. Goldman-Rakic.  The cortical dopamine system: role in memory and cognition. , 1998, Advances in pharmacology.

[23]  H. Maeno,et al.  Dopamine Receptors , 2018 .

[24]  P. Goldman-Rakic,et al.  Characterization of the dopaminergic innervation of the primate frontal cortex using a dopamine-specific antibody. , 1993, Cerebral cortex.

[25]  J. Bolam,et al.  Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[26]  F. J. White,et al.  Synaptic regulation of mesocorticolimbic dopamine neurons. , 1996, Annual review of neuroscience.

[27]  J. Meador-Woodruff,et al.  Linking the Family of D2 Receptors to Neuronal Circuits in Human Brain: Insights into Schizophrenia , 1997, Neuropsychopharmacology.

[28]  K. Neve,et al.  Increased abundance of alternatively spliced forms of D2 dopamine receptor mRNA after denervation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[29]  P. Calabresi,et al.  Abnormal Synaptic Plasticity in the Striatum of Mice Lacking Dopamine D2 Receptors , 1997, The Journal of Neuroscience.